[수상]
•라파엘 클리닉 2008 - 미카엘상 : 사회복지법인 서울카톨릭사회복지회
•대한 위암학회 2013 - 제 18회 사노피-아벤티스 우수논문 발표상 : The Impact of Screening Test on Gastic Cancer Treatment: Comparison of 2011 to 2006
•Global Breast Cancer Conference 2016 - Yong Investigator Award : The risk factors of pregnancy-associated breast cancer in Korean women
•대진의료재단 분당제생병원 2020 – 표창장 : 친절직원상
[주요 논문]
1. Right paraesophageal Lymph Node Metastasis in Papillary Thyroid Cancer Prophylactic Dissection : A Retrospective Study ; Korean J Endocrine Surgery 2013:13:77-82
2. Effect of Screening on Gastric Cancer Management : Comparative Analysis of the Results in 2006 in 2011 ; J Gastric Cancer 2014:14(2):129-134
3. Survival Improvement in Korean Breast Cancer Patients Due to Increases in Early-Stage Cancers Hormone Receptor Positive/HER2 Negative Subtypes : A Nationwide Registry-Based Study ; J Breast Cancer 2015 March:18(1):8-15
4. Risk Factors Associated with Distant Metastasis Survival Outcomes in Breast Cancer Patients with Locoregional Recurrence ; J Breast Cancer 2015:June;18(2):160-166
5. In Vivo Tumor Growth Rate Measured by US in Preoperative Period Long Term Disease Outcome in Breast Cancer Patients ; PLoS ONE 2015:10(12)
Identifying the potential long-term survivors among breast cancer patients with distant metastasis ; Annals of Oncology 2016:mdw036
6. Prognostic Value of Anti-MUllerian Hormone Inhibin B in Patients with Premenopausal Hormone Receptor-positive Breast Cancer ; Anticancer research 2016:36(3):1051-57
7. The Molecular Subtype Dependent Effect of Concurrent Radiotherapy Systemic Therapy on Breast Cancer: Analysis of a Human In Vivo Model of Metastatic Brain Lesions ; J Breast Dis 2016:December:4(2)85-91
8. Clinicopathologic Characteristics of Pregnancy-Associated Breast Cancer: Results of Analysis of a Nationwide Breast Cancer Registry Database ; J Breast Cancer 2017 September:20(3)264-9
9. Factors Associated with Metastatic Breast Cancer in Patients Who Show Long-Term Stable Disease Status ; J Breast dis 2017 June:5(1):1-7
10. Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer ; Oncotarget 2018:9(5):5811-22
11. Inhibition of tamoxifen’s therapeutic effect by emodin in estrogen-positive breast cancer cell lines ; Annals of Surgical Treatment and Research 2019;97(5):230-238